DIVA Laboratories Ltd (4153) — Cash Flow Quality Index
DIVA Laboratories Ltd (4153) has a Cash Flow Quality Index of 0.19x as of December 2025. Operating cash flow of NT$5.57 Million is below net income of NT$29.81 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore DIVA Laboratories Ltd operating cash flow efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
DIVA Laboratories Ltd Cash Flow Quality Index (2018–2025)
Historical Cash Flow Quality Index for DIVA Laboratories Ltd across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 4153 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for DIVA Laboratories Ltd (2018–2025)
Year-by-year earnings quality comparison for DIVA Laboratories Ltd. For live market cap and the full company financial profile, see DIVA Laboratories Ltd market capitalisation.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.23x | NT$20.77 Million | NT$90.54 Million | ▼ -82.6% |
| 2024 | 1.31x | NT$123.14 Million | NT$93.66 Million | ▼ -61.7% |
| 2023 | 3.44x | NT$252.91 Million | NT$73.62 Million | ▲ +217.5% |
| 2022 | 1.08x | NT$73.19 Million | NT$67.64 Million | ▲ +370.4% |
| 2021 | -0.40x | NT$-11.39 Million | NT$28.47 Million | ▲ +33.8% |
| 2020 | -0.60x | NT$-16.64 Million | NT$27.55 Million | ▼ -175.1% |
| 2019 | 0.80x | NT$52.66 Million | NT$65.45 Million | ▼ -51.2% |
| 2018 | 1.65x | NT$86.02 Million | NT$52.15 Million | — |